Related Experiment Video
Updated: Jan 8, 2026
Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
Published on: April 7, 2018
Application of Macroscopic On-Site Evaluation With Adjustable Light Source in EUS-FNA for Solid Pancreatic Masses
Mengyi Deng1, Dan Luo1, Xianhao Tan2
1Department of Gastroenterology, The Third People's Hospital of Chengdu (Affiliated Hospital of Southwest Jiaotong University), College of Medicine, Southwest Jiaotong University.
Objective:
To further enhance the evaluation capabilities of Macroscopic On-site Evaluation (MOSE) for EUS-FNA, we developed a device featuring an adjustable light source, in the hope of more efficient observation of FNA specimens. Then we modified MOSE with this device and compared it with the traditional MOSE in assessing specimen adequacy and diagnostic accuracy.
Methods:
This is a single-center cross-randomized controlled trial. Patients with pancreatic solid masses undergoing EUS-FNA (22G/25G) were enrolled, and 2 punctures were conducted with a different sequence of traditional or modified MOSE. Specimens were classified as insufficient if the macroscopic visible core (MVC) <4 mm. Each puncture was independently submitted for pathology analysis.
Results:
A total of 90 patients were included in the study, yielding 180 FNA specimens. Modified MOSE demonstrated greater consistency with pathologic assessments of specimen adequacy compared with traditional MOSE, with accuracy rates of 71.1% and 50%, respectively (P=0.004). The diagnostic accuracy rate of the samples evaluated as adequate by traditional MOSE was 81.0% and 96.8% by modified MOSE (P=0.019).
Conclusion:
The use of modified MOSE for 22G/25G FNA specimens allows for a more precise determination of specimen adequacy, thus enhancing diagnostic accuracy and assisting endosonographers in determining the optimal endpoint for puncture.
